Precise Health raises funding

Precise Health develops personalised bacteriophage technology to replace broad-spectrum antibiotics. The start-up has joined the Biopôle Investment Programme, which offers non-dilutive funding of up to CHF 90,000.

Announced on
Round
Grant
Amount
Amount not disclosed
Location
canton of Valais
Sector
Biotech & life sciences

Investors

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic